BNP/CALL/STRYKER CORP./250/0.1/20.12.24 Stock

Warrant

DE000PN38H05

Delayed Deutsche Boerse AG 07:21:10 2024-06-28 EDT
9.12 EUR +0.44% Intraday chart for BNP/CALL/STRYKER CORP./250/0.1/20.12.24
Current month+1.45%
1 month+3.18%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-28 9.12 +0.44%
24-06-27 9.08 -0.44%
24-06-26 9.12 +2.82%
24-06-25 8.87 -1.55%
24-06-24 9.01 -2.49%

Delayed Quote Deutsche Boerse AG

Last update June 28, 2024 at 07:21 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PN38H0
ISINDE000PN38H05
Date issued 2023-06-02
Strike 250 $
Maturity 2024-12-20 (176 Days)
Parity 10 : 1
Emission price 5.47
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 11.18
Lowest since issue 3.85
Delta0x
Omega 0.000000
Premium0x
Gearing0x
Moneyness 1.362
Difference Strike -90.54 $
Difference Strike %-36.22%
Intrinsic value 8.458

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
340.5 USD
Average target price
372.9 USD
Spread / Average Target
+9.51%
Consensus